Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APLS Apellis Pharmaceuticals Inc.

未开盘 11-26 16:00:00 EST

32.63

+0.72

+2.26%

盘后32.70

+0.07+0.21%

19:26 EST

最高32.98	最低31.80	成交量330.21万
今开32.29	昨收31.91	日振幅3.70%
总市值40.59亿	流通市值26.72亿	总股本1.24亿
成交额1.07亿	换手率4.03%	流通股本8,189万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"APLS","market":"US","secType":"STK","nameCN":"Apellis Pharmaceuticals Inc.","latestPrice":32.63,"timestamp":1732654800000,"preClose":31.91,"halted":0,"volume":3302069,"hourTrading":{"tag":"盘后","latestPrice":32.7,"preClose":32.63,"latestTime":"19:26 EST","volume":1693990,"amount":55273901.63,"timestamp":1732667180611},"delay":0,"floatShares":81885700,"shares":124393017,"eps":-2.031999,"marketStatus":"未开盘","marketStatusCode":0,"change":0.72,"latestTime":"11-26 16:00:00 EST","open":32.29,"high":32.98,"low":31.8,"amount":107443005.099934,"amplitude":0.036979,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.031999,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":0,"listingDate":1510203600000,"adjPreClose":31.91,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":32.26,"preClose":31.91,"latestTime":"09:29 EST","volume":104,"amount":3353.639744,"timestamp":1732631399999},"postHourTrading":{"tag":"盘后","latestPrice":32.7,"preClose":32.63,"latestTime":"19:26 EST","volume":1693990,"amount":55273901.63,"timestamp":1732667180611},"volumeRatio":0.611338,"impliedVol":0.6646,"impliedVolPercentile":0.2964},"requestUrl":"/m/hq/s/APLS","defaultTab":"news","newsList":[{"id":"2485414473","title":"Apellis Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.07%报27.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485414473","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485414473?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:40","pubTimestamp":1732120835,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时40分，Apellis Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.07%。截至发稿，该股报27.52美元/股，成交量86.8153万股，换手率0.70%，振幅4.78%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004035abd26c4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004035abd26c4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLS","LU1093756325.SGD","BK4505","BK4585","BK4139","BK4588","LU1093756168.USD"],"gpt_icon":0},{"id":"2484715456","title":"美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715456?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:56","pubTimestamp":1732085774,"startTime":"0","endTime":"0","summary":"    路透11月20日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Apellis Pharmaceuticals、Energizer Holdings 和沃尔玛。要闻              * Apellis Pharmaceuticals Inc   ：摩根大通将目标价从57美元下调至50美元             * Chord Energy Corp   ：加拿大皇家银行将目标价从185美元下调至180美元             * Energizer Holdings Inc   ：摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","CASY","CHRD","LOW","BBIO","VVV","AZEK","PBF","BK4187","MNPR","BK4528","LU0006061336.USD","LU2430703251.USD","PIII","LU1267930490.SGD","AVAV","BERY","LU0528227936.USD","SWTX","LU1551013425.SGD","LU1988902786.USD","NOG","FSUN","LH","BK4086","APLS","LU0265550946.USD","NUVL","IE00B19Z8X17.USD","BRBR","BK4596","OLMA","LU0310799852.SGD","ANNX","VERA","IIIV","WMT","ENR","DYN","VIR","LU2756315318.SGD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU2286300806.USD","OCSL","BK4505","LU1951198990.SGD","BK4579","CRM","TVTX"],"gpt_icon":0},{"id":"2484289019","title":"Apellis Pharmaceuticals, Inc.盘中异动 股价大涨8.98%报28.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484289019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484289019?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:31","pubTimestamp":1732026682,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时31分，Apellis Pharmaceuticals, Inc.股票出现波动，股价大幅拉升8.98%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922312295be4a81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922312295be4a81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","APLS","LU1093756325.SGD","BK4139","LU1093756168.USD","BK4588"],"gpt_icon":0},{"id":"2482620192","title":"Apellis Pharmaceuticals, Inc.2024财年第三财季实现净利润-57.45百万美元，同比增加58.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482620192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482620192?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254457,"startTime":"0","endTime":"0","summary":"11月11日，Apellis Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-57.45百万美元，同比增加58.96%；其中营业收入为1.97亿美元，同比增加79.09%，每股基本收益为-0.46美元。从资产负债表来看，Apellis Pharmaceuticals, Inc.总负债6.65亿美元，其中短期债务6.79百万美元，资产负债比为1.36，流动比率为4.37。机构评级：截至2024年11月11日，当前有19家机构对Apellis Pharmaceuticals, Inc.目标价做出预测，其中目标均价为46.79美元，其中最低目标价为24.00美元，最高目标价为78.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000115a229e3c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000115a229e3c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLS"],"gpt_icon":0},{"id":"2481624519","title":"美国研究综述-阿波罗、Booking Holdings、Portillos","url":"https://stock-news.laohu8.com/highlight/detail?id=2481624519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481624519?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:15","pubTimestamp":1730884501,"startTime":"0","endTime":"0","summary":"    路透11月6日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括阿波罗、Booking Holdings 和 Portillos。要闻 * 阿波罗  ：摩根大通将目标价从143美元上调至161美元 * Aris Water Solutions Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Booking Holdings Inc   ：Truist Securities将目标价从4100美元上调至4700美元  * Choice Hotels International Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * Portillos Inc   ：Stifel将其评级从 \"买入 \"下调至 \"持有  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMI","BK4113","BOW","GO","AIG","CE","EMN","BEAM","CTRE","ACLX","APO","LU0029874061.USD","EXAS","DBRG","CC","ALL","BKNG","BK4141","HPK","APLS","BVS","AVB","FIS","CHH","BRKR","GXO","LU0390134368.USD","LU2065171311.SGD","MO","AGCO","BR","LU0426417589.USD","ADUS","INZY","FRPT","ARIS","LU0708994859.HKD","BLDR","ABNB","LU0868494708.USD","GMED","AHCO","ABBV","ANAB","IT","EMR","AMH","LU2065169927.USD","AZPN","GFS"],"gpt_icon":0},{"id":"1137221640","title":"异动解读 | Apellis Pharmaceuticals Inc. 第三季报亏损扩大股价重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1137221640","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137221640?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:36","pubTimestamp":1730821005,"startTime":"0","endTime":"0","summary":"北京时间2024年11月5日,生物制药公司 Apellis Pharmaceuticals Inc. 股价当日大幅下跌14.53%,跌至26美元左右,引发了市场的广泛关注。APLS股价暴跌的主要原因是该公司近期公布的2024年第三季度业绩不佳。具体来看,APLS第三季度亏损46美分/每股,远高于市场预期的30美分/每股亏损。SYFOVRE是APLS一款治疗地理性黄斑变性疾病的创新产品,本应成为未来营收增长的主要动力。但由于遭欧盟人用药委员会否定,该产品的上市前景存在不确定性,加剧了投资者对APLS的担忧情绪。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLS"],"gpt_icon":0},{"id":"1182910106","title":"异动解读 | Apellis Pharmaceuticals Inc.盘前大跌14%,业绩不佳拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1182910106","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182910106?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:48","pubTimestamp":1730818130,"startTime":"0","endTime":"0","summary":"生物制药公司Apellis Pharmaceuticals Inc. 股价在2024年11月5日盘前大跌14.11%,引发市场关注。这一大幅下跌或与该公司近期公布的第三季度业绩不佳有关。APLS第三季度亏损46美分/每股,远超预期的30美分/每股。业绩低于预期导致投资者对公司前景失去信心,抛售该股。另一个重要因素是APLS旗舰产品SYFOVRE注射液遭到欧盟人用药委员会否定,给公司业务前景带来不确定性。SYFOVRE是一款治疗地理性黄斑变性疾病的创新产品,其销售在第三季度也出现下滑,进一步拖累了公司业绩。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLS"],"gpt_icon":0},{"id":"2481688879","title":"BUZZ-Apellis 制药公司第三季度亏损扩大，业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688879","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688879?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:42","pubTimestamp":1730817751,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    11月5日 - ** 生物制药公司Apellis Pharmaceuticals   股价下跌8.9%至26.02美元** APLS 以近三个月低点开盘** 该公司公布的第三季度亏损超出预期  ** 第三季度亏损46美分/每小时，预计亏损30美分/每小时 - LSEG ** 公司第三季度实现营业收入 1.968 亿美元，预计为 2.0035 亿美","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CHMP","LU1093756325.SGD","BK4585","BK4505","APLS","LU1093756168.USD","BK4139","BK4087"],"gpt_icon":0},{"id":"2481468850","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘快速下跌9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481468850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481468850?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817100,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速下跌9.26%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522314095bdd1d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522314095bdd1d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","LU1093756168.USD","LU1093756325.SGD","APLS","BK4505","BK4139"],"gpt_icon":0},{"id":"2480878715","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.09%报29.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480878715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480878715?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:08","pubTimestamp":1730732886,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时08分，Apellis Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.09%。截至发稿，该股报29.41美元/股，成交量49.5104万股，换手率0.41%，振幅6.81%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230806971a42fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230806971a42fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","APLS","BK4505","BK4139","BK4585","LU1093756325.SGD","BK4588"],"gpt_icon":0},{"id":"2477894190","title":"Apellis Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%报26.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477894190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477894190?lang=zh_cn&edition=full","pubTime":"2024-10-22 01:57","pubTimestamp":1729533434,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日01时57分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.00%。截至发稿，该股报26.60美元/股，成交量61.113万股，换手率0.50%，振幅4.93%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022015714ab6bca28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022015714ab6bca28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BK4588","BK4505","BK4585","BK4139","LU1093756168.USD","APLS"],"gpt_icon":0},{"id":"2469492463","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469492463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469492463?lang=zh_cn&edition=full","pubTime":"2024-09-24 22:14","pubTimestamp":1727187284,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日22时14分，Apellis Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.17%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242214459719c678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242214459719c678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","LU1093756325.SGD","BK4505","APLS","LU1093756168.USD"],"gpt_icon":0},{"id":"2469165497","title":"美国研究综述-Cardinal Health、Factset、Paylocity Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2469165497","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469165497?lang=zh_cn&edition=full","pubTime":"2024-09-23 15:33","pubTimestamp":1727076787,"startTime":"0","endTime":"0","summary":"    路透9月23日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括卡地纳健康、Factset 和 Paylocity Holding。要闻              * Cardinal Health Inc   ：贝尔德将目标价从137美元上调至140美元             * Factset   ：杰富瑞将目标价从435美元上调至486美元             * Marinus Pharmaceuticals Inc   ：奥本海默将其评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。* Paylocity Holding Corp   ：TD Cowen将目标价从171美元上调至186美元             * United Rentals Inc   ：摩根大通将目标价从780美元上调至940美元 以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RBLX","BK4112","FDS","LU0310799852.SGD","LU1861559042.SGD","URI","CRBP","LU1201861249.SGD","LU1861558580.USD","CRMT","BK4559","LU0310800965.SGD","LU0477156953.USD","LU2517655028.SGD","PCTY","LU1201861165.SGD","BK4516","LU2264538146.SGD","LU0211327993.USD","LU1917777945.USD","LU0211331839.USD","MRNS","LU2517655291.USD","BK4567","LU0130103400.USD","LEN","IE00BFXG1179.USD","LU0724618433.USD","LU1093756325.SGD","BK4566","LU1880398554.USD","PYCR","LU0006061336.USD","MLKN","BK4551","TNET","UTHR","F","LU0162691827.USD","LU0980610538.SGD","GEV","GM","KVUE","BK4099","LU0477156797.USD","LU2517655374.HKD","LU1169590202.USD","LU0211328371.USD","CAH","APLS"],"gpt_icon":0},{"id":"2469679124","title":"BUZZ-欧盟专家组确认对眼疾药物持否定意见，Apellis业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2469679124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469679124?lang=zh_cn&edition=full","pubTime":"2024-09-21 01:01","pubTimestamp":1726851662,"startTime":"0","endTime":"0","summary":" (更新)    9月20日 - ** Apellis制药公司  股价下跌14.3%至31.46美元，创下自2023年8月以来的最低水平 。** Apellis称欧洲药品监管机构的人用医药产品委员会 已确认对其实验性药物培西他克普兰持否定意见** Pegcetacoplan是一种治疗地理性萎缩的试验性药物，地理性萎缩是一种渐进性和不可逆的眼部疾病，是由于病变的生长破坏了负责视力的视网膜细胞而引起的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHMP","BK4585","BK4588","BK4087","LU1093756168.USD","LU1093756325.SGD","APLS","BK4505","BK4139"],"gpt_icon":0},{"id":"2469729673","title":"BUZZ--美国股票走势-纽蒙特公司、耐克公司、和谐金矿公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2469729673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469729673?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:09","pubTimestamp":1726848585,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月20日 - 周五，华尔街主要股指下滑，原因是投资者在前一交易日因美联储大幅降息引发的反弹后按兵不动。美东时间11:33，道琼斯工业平均指数  下跌0.15%，报41,962.62点。标普500指数  下跌0.56%，报5,681.91点；纳斯达克综合指数  下跌0.91%，报17,850.471点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4570","FDX","LU2095319765.USD","LU0289961442.SGD","LU1668664300.SGD","DJX","LU1861559042.SGD","LU2210150020.SGD","ERIE","CRBP","NEM","LU1244550221.USD","RPD","LEN","APLS","VC","BK4207","DXD","LU1236620834.HKD","BK4515","BK4566","DDM","SDOW","SGXZ51526630.SGD",".IXIC","LU2265009873.SGD","ARQ","LU0097036916.USD","LU1023059493.AUD","LU1366192091.USD","CEG","LU0011850046.USD","LU0310800965.SGD",".DJI","APTV","PEP","NKE","INTU","DAN",".SPX","CHWY","LU1363072403.SGD","BAC","LU1496350171.SGD","DOG","UDOW","LU0149725797.USD"],"gpt_icon":1},{"id":"2468539625","title":"BUZZ--美国股票走势-Constellation Energy、Gold Fields、NovaBay Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2468539625","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468539625?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:30","pubTimestamp":1726839004,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月20日 - 华尔街主要股指周五开盘表现平淡，因为投资者在美联储超预期降息引发的前一交易日反弹后按兵不动。美东时间9:19，道指电子盘  下跌0.11%，报42,010点。标普500指数小型股  下跌0.26%，报5703点；纳斯达克100指数小型股  下跌0.30%，报19791.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223082519.USD","APLS","LU0417517546.SGD","LU2249611893.SGD","LU2129689514.USD","LU0320765489.SGD","LU0149725797.USD","LU1878469433.USD","LU0390134368.USD","LU1496350502.SGD","LU1712237335.SGD","IE00B7SZLL34.SGD","APTV","LU0742534661.SGD","BK4504","LU0456854461.SGD","BK4588","LU1941712348.USD","LU2129689431.USD","LU2129689605.HKD","BK4097","BK4570","NEM","LU0612318385.USD","LU1894683264.USD","LU0306807586.USD","BK4581","BK4585","LU1623119135.USD","BK4017","IE00BKVL7J92.USD","CSTA.U","CEG","LU1074936037.SGD","LU0300736492.USD","BK4122","BK4139","BK4505","IE00BFXG1179.USD","BK4131","IE00B19Z3581.USD","LU0498741890.SGD","RPD","LU0306806265.USD","LU0256863811.USD","LU0048573561.USD"],"gpt_icon":1},{"id":"2468471716","title":"BUZZ--美国股票走势-耐克、巴蒂尔石油公司、金矿工人","url":"https://stock-news.laohu8.com/highlight/detail?id=2468471716","media":"Reuters","labels":["Executive Changes","Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468471716?lang=zh_cn&edition=full","pubTime":"2024-09-20 20:23","pubTimestamp":1726835026,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月20日 - 美国股指期货周五走低，暂停了前一交易日的涨势，在美联储本周早些时候对货币政策采取关键立场后，华尔街主要股指有望实现周涨幅。标普500指数小型股  下跌0.15%，报5,709.25点；纳斯达克100指数小型股  下跌0.20%，报19,810点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes,Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","BK4139","LU0256863902.USD","LU2098885051.SGD","RPD","BK4017","LU1162221912.USD","LU0048573561.USD","BK4588","LU1303367103.USD","LU0055631609.USD","LU1366192091.USD","SG9999001143.SGD","LU1074936037.SGD","LU0306806265.USD","LU0310800965.SGD","BK4505","LU1668664300.SGD","BK4207","FDX","LU0128525689.USD","BK4581","BK4504","BK4561","BK4570","LU0640476718.USD","LU1023059493.AUD","BK4131","LU0971096721.USD","LU1496350171.SGD","IE00BFXG1179.USD","IE00B19Z3581.USD","LU0742534661.SGD","LU0052756011.USD","NEM","LU1718418525.SGD","LU1363072403.SGD","IE00BKVL7J92.USD","NKE","LU0149725797.USD","BK4585","LU0786609619.USD","APLS","LU2129689605.HKD","LU0306807586.USD","LU1496350502.SGD","LU0070302665.USD","LU0300736492.USD","LU0320765489.SGD"],"gpt_icon":1},{"id":"2468344646","title":"BUZZ-欧盟专家组确认对眼疾药物持否定意见，Apellis 公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2468344646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468344646?lang=zh_cn&edition=full","pubTime":"2024-09-20 18:51","pubTimestamp":1726829515,"startTime":"0","endTime":"0","summary":"    9月20日 - ** Apellis制药公司  股价盘前下跌3.7%至35.36美元 ** Apellis称欧洲药品监管机构的人用医药产品委员会 已确认对其实验性药物培西他克普兰持否定意见** Pegcetacoplan是一种治疗地理性萎缩的试验性药物，地理性萎缩是一种渐进性和不可逆的眼病，是由于病变的生长破坏了负责视力的视网膜细胞而引起的。** APLS 于 6 月份寻求重新审查  CHMP 对该药上市申请的负面意见 ** 截至上次收盘，该股累计下跌约 39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","APLS","BK4505","BK4585","LU1093756168.USD","LU1093756325.SGD","BK4588","BK4139","CHMP"],"gpt_icon":0},{"id":"2468035645","title":"Apellis Pharmaceuticals, Inc.盘中异动 急速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468035645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468035645?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:04","pubTimestamp":1726754680,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时04分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.25%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220441a1db3331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220441a1db3331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","BK4588","BK4585","LU1093756325.SGD","BK4505","APLS"],"gpt_icon":0},{"id":"2459476344","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.05%报37.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476344","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476344?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:33","pubTimestamp":1723732393,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时33分，Apellis Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报37.84美元/股，成交量19.9541万股，换手率0.16%，振幅3.97%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522331397198d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522331397198d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLS","BK4585","BK4505","BK4139","LU1093756168.USD","BK4588","LU1093756325.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apellis.com","stockEarnings":[{"period":"1week","weight":0.1256},{"period":"1month","weight":0.223},{"period":"3month","weight":-0.1454},{"period":"6month","weight":-0.1993},{"period":"1year","weight":-0.3243},{"period":"ytd","weight":-0.4549}],"compareEarnings":[{"period":"1week","weight":0.0175},{"period":"1month","weight":0.0373},{"period":"3month","weight":0.0759},{"period":"6month","weight":0.1493},{"period":"1year","weight":0.3216},{"period":"ytd","weight":0.2637}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apellis Pharmaceuticals, Inc.于2009年9月25日根据德拉华州法律成立。该公司是一家商业阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过在补体级联中的中心蛋白C3水平上抑制补体系统（作为免疫系统的一个组成部分）来治疗具有高度未满足需求的疾病。2023年2月，美国食品药品监督管理局（FDA）批准了SYFOVRE，这是首个获批治疗继发于年龄相关性黄斑变性（GA）的地理萎缩的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.018331},{"month":2,"riseRate":0.714286,"avgChangeRate":0.056236},{"month":3,"riseRate":0.571429,"avgChangeRate":0.044074},{"month":4,"riseRate":0.714286,"avgChangeRate":0.062825},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.025158},{"month":6,"riseRate":0.714286,"avgChangeRate":0.080149},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.099521},{"month":8,"riseRate":0.857143,"avgChangeRate":0.144378},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.143331},{"month":10,"riseRate":0.428571,"avgChangeRate":0.015269},{"month":11,"riseRate":0.714286,"avgChangeRate":0.141032},{"month":12,"riseRate":0.857143,"avgChangeRate":0.150428}],"exchange":"NASDAQ","name":"Apellis Pharmaceuticals Inc.","nameEN":"Apellis Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apellis Pharmaceuticals Inc.(APLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apellis Pharmaceuticals Inc.,APLS,Apellis Pharmaceuticals Inc.股票,Apellis Pharmaceuticals Inc.股票老虎,Apellis Pharmaceuticals Inc.股票老虎国际,Apellis Pharmaceuticals Inc.行情,Apellis Pharmaceuticals Inc.股票行情,Apellis Pharmaceuticals Inc.股价,Apellis Pharmaceuticals Inc.股市,Apellis Pharmaceuticals Inc.股票价格,Apellis Pharmaceuticals Inc.股票交易,Apellis Pharmaceuticals Inc.股票购买,Apellis Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apellis Pharmaceuticals Inc.(APLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}